AFP and hepatocellular carcinoma: Baseline comparison was performed in all the 15 studies, and no significant difference was found between both groups in terms of age, gender ratio, Child-Pugh grade, percentage of HBeAg-positive patients, HBV DNA level, presence of cirrhosis, tumor stage, AFP level, and HCC treatment.